CervoMed Inc. (CRVO)
Pharmaceutical Preparations
Latest Price
$2.53
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
2.35
P/B Ratio
1.07
Valuation metrics
adjust assumptions →EPS: $2038891.00
Book value / share: $1.97
Formula: √(22.5 × EPS × BVPS)
Graham Number
$9,505.22
+375601% upside
EPS: $2038891.00
Target P/E: 15×
Formula: EPS × P/E
P/E Fair Value
$30,583,365.00
+1208828556% upside
Institutional Ownership
12.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Woodline Partners LP | 689.0K | $2.0M | 5.09% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 316.2K | -- | 2.34% | -- | 2026-06-30 |
| SABBY MANAGEMENT, LLC | 248.9K | -- | 1.84% | -- | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 66.9K | -- | 0.49% | -7.4K | 2026-06-30 |
| BlackRock, Inc. | 53.8K | -- | 0.40% | +2.2K | 2026-06-30 |
| Byrne Asset Management LLC | 51.3K | -- | 0.38% | +36.5K | 2026-06-30 |
| CITIZENS FINANCIAL GROUP INC/RI | 37.5K | -- | 0.28% | -- | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 36.2K | -- | 0.27% | -- | 2026-06-30 |
| JANE STREET GROUP, LLC | 32.2K | -- | 0.24% | +14.0K | 2026-06-30 |
| THOMPSON DAVIS & CO., INC. | 29.8K | -- | 0.22% | +19.8K | 2026-06-30 |